Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J WainC M Parry

Abstract

Nalidixic acid-resistant Salmonella typhi (NARST) was first isolated in Viet Nam in 1993. Analysis of the quinolone resistance-determining region of gyrA in 20 NARST isolates by polymerase chain reaction and single-stranded conformational polymorphism yielded two novel patterns: pattern II corresponding to a point mutation at nucleotide 87 Asp-->Gly (n = 17), and pattern III corresponding to a point mutation at nucleotide 83 Ser-->Phe (n = 3). In trials of short-course ofloxacin therapy for uncomplicated typhoid, 117 (78%) of 150 patients were infected with multidrug-resistant S. typhi, 18 (15%) of which were NARST. The median time to fever clearance was 156 hours (range, 30-366 hours) for patients infected with NARST and 84 hours (range, 12-378 hours) for those infected with nalidixic acid-susceptible strains (P < .001). Six (33.3%) of 18 NARST infections required retreatment, whereas 1 (0.8%) of 132 infections due to susceptible strains required retreatment (relative risk = 44; 95% confidence interval = 5.6-345; P < .0001). We recommend that short courses of quinolones not be used in patients infected with NARST.

Citations

Aug 14, 2012·Current Microbiology·Fernanda L S SebastianesDiego Cortes
Apr 10, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S HumeJ Torresi
Jul 17, 2003·Current Gastroenterology Reports·Nancy F Crum
Apr 15, 2004·International Journal of Antimicrobial Agents·F AlbayrakA D Aysev
Mar 24, 2005·International Journal of Antimicrobial Agents·M Mushfequr RahmanM Atiqur Rahman
May 13, 2004·Transactions of the Royal Society of Tropical Medicine and Hygiene·Christopher M Parry
May 13, 2004·Transactions of the Royal Society of Tropical Medicine and Hygiene·John Wain, Claire Kidgell
Apr 20, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Simmaly PhongmanyPaul N Newton
Aug 16, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·H H TranP J Guerin
Oct 4, 2006·Transactions of the Royal Society of Tropical Medicine and Hygiene·Fiona J CookeE John Threlfall
Sep 7, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·H VinhC M Parry
Dec 23, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·N T HoaN J White
May 20, 1999·Lancet·E J ThrelfallS Lacey
May 15, 2002·FEMS Microbiology Reviews·Laura J V Piddock
Oct 3, 2003·International Journal of Antimicrobial Agents·Jennifer M StephenRonald N Jones
Apr 30, 1999·International Journal of Antimicrobial Agents·D J MeviusH C Wegener
Apr 12, 2002·The Lancet Infectious Diseases·John WainGordon Dougan
Sep 5, 2003·The Lancet Infectious Diseases·Dominique GendrelJosette Raymond
Aug 8, 2012·Nature Reviews. Genetics·Xavier DidelotDerrick W Crook
Jul 18, 2006·Nature Reviews. Microbiology·Laura J V Piddock
Nov 5, 1999·The New England Journal of Medicine·K MølbakH C Wegener
Apr 26, 2001·The New England Journal of Medicine·F Y LinS C Szu
Apr 26, 2001·The New England Journal of Medicine·R L Guerrant, M Kosek
Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R CarnevaleF M Aarestrup
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R W FrenckM Morsy
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L Hohmann
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D C Hooper
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Camilla RodriguesV R Joshi
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A CrumpFrederick J Angulo
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashish P MaskeyBuddha Basnyat
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Graham S CookeKathleen B Bamford
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Anna RiberaJordi Vila
Jul 17, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·K RenukaP Seth
Jun 27, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·C WiuffF M Aarestrup
Feb 13, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J G T VehreschildUNKNOWN German Society of Hematology and Oncology
Jul 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Romney M HumphriesJanet A Hindler
Oct 7, 2006·Current Opinion in Gastroenterology·G S Murphy, P Echeverria
Jan 5, 2011·Antimicrobial Agents and Chemotherapy·John A CrumpUNKNOWN Emerging Infections Program NARMS Working Group
Jan 24, 2008·Antimicrobial Agents and Chemotherapy·John A CrumpUNKNOWN Emerging Infections Program FoodNet and NARMS Working Groups

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.